Drug recall · November 22, 2017
Clolar (clofarabine) 20 mg/20 mL recall
Why: Labeling: Incorrect or Missing Package Insert.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
- Lots / codes
Lot #: K5006Y01; Exp. 08/31/18 Lot #: K5006Y03; Exp. 08/31/18 Lot #: K6001Y01; Exp. 03/31/19
- Quantity
- 9,343 single dose vials
- Company
- Genzyme Corporation, Northborough, MA
- Distribution
- Nationwide
- Initiated
- October 12, 2017 · Voluntary: Firm initiated
- Classified
- November 10, 2017
- Reported
- November 22, 2017
- Ended
- September 10, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clofarabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.